RecruitingPhase 2/3

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Greece100 participantsStarted 2019-01-23

Plain-language summary

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.

Who can participate

Age range35 Years – 47 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 40 years
✓. AMH \< 1.1 ng/ml OR AFC \< 7
✓. ≤ 3 oocytes with a conventional stimulation protocol

What they're measuring

Number of oocytes retrieved

Timeframe: 34-36 hours following ovulation triggering

Anti-Müllerian Hormone Levels (AMH)

Timeframe: On day 2-3 of the first menstrual cycle post intervention

Trial details

NCT IDNCT05181748

SponsorGenesis Athens Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

Agni Pantou, M.D

+306974447702 agni.pantou@genesisathens.gr

View on ClinicalTrials.gov More Poor Response to Ovulation Induction trials